nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—DRD2—nicotine dependence	0.838	1	CbGaD
Ergotamine—Ergoloid mesylate—DRD2—nicotine dependence	0.004	0.561	CrCbGaD
Ergotamine—HTR1F—brain—nicotine dependence	0.00238	0.0691	CbGeAlD
Ergotamine—HTR1E—brain—nicotine dependence	0.00206	0.0598	CbGeAlD
Ergotamine—HTR1B—cardiovascular system—nicotine dependence	0.00199	0.0577	CbGeAlD
Ergotamine—HTR1D—cardiovascular system—nicotine dependence	0.00192	0.0558	CbGeAlD
Ergotamine—HTR2B—cardiovascular system—nicotine dependence	0.00179	0.0519	CbGeAlD
Ergotamine—Lisuride—DRD2—nicotine dependence	0.00162	0.228	CrCbGaD
Ergotamine—HTR1A—cardiovascular system—nicotine dependence	0.0016	0.0465	CbGeAlD
Ergotamine—HTR1B—midbrain—nicotine dependence	0.00155	0.045	CbGeAlD
Ergotamine—Bromocriptine—DRD2—nicotine dependence	0.0015	0.211	CrCbGaD
Ergotamine—HTR1D—midbrain—nicotine dependence	0.0015	0.0436	CbGeAlD
Ergotamine—HTR2C—midbrain—nicotine dependence	0.00149	0.0432	CbGeAlD
Ergotamine—ADRA1A—cardiovascular system—nicotine dependence	0.00148	0.0429	CbGeAlD
Ergotamine—ADRA1B—brain—nicotine dependence	0.00129	0.0375	CbGeAlD
Ergotamine—ADRA1D—brain—nicotine dependence	0.00126	0.0366	CbGeAlD
Ergotamine—HTR1A—midbrain—nicotine dependence	0.00125	0.0363	CbGeAlD
Ergotamine—DRD2—midbrain—nicotine dependence	0.00113	0.0328	CbGeAlD
Ergotamine—HTR1B—brain—nicotine dependence	0.000974	0.0283	CbGeAlD
Ergotamine—HTR2A—cardiovascular system—nicotine dependence	0.000955	0.0277	CbGeAlD
Ergotamine—HTR1D—brain—nicotine dependence	0.000943	0.0274	CbGeAlD
Ergotamine—HTR2C—brain—nicotine dependence	0.000934	0.0271	CbGeAlD
Ergotamine—HTR2B—brain—nicotine dependence	0.000877	0.0255	CbGeAlD
Ergotamine—ADRA2A—midbrain—nicotine dependence	0.000877	0.0255	CbGeAlD
Ergotamine—HTR1A—brain—nicotine dependence	0.000786	0.0228	CbGeAlD
Ergotamine—SLC6A2—brain—nicotine dependence	0.000779	0.0226	CbGeAlD
Ergotamine—HTR2A—midbrain—nicotine dependence	0.000746	0.0217	CbGeAlD
Ergotamine—ADRA1A—brain—nicotine dependence	0.000725	0.021	CbGeAlD
Ergotamine—DRD2—brain—nicotine dependence	0.00071	0.0206	CbGeAlD
Ergotamine—ABCB1—cardiovascular system—nicotine dependence	0.000626	0.0182	CbGeAlD
Ergotamine—ADRA2A—brain—nicotine dependence	0.000551	0.016	CbGeAlD
Ergotamine—ABCB1—midbrain—nicotine dependence	0.000489	0.0142	CbGeAlD
Ergotamine—HTR2A—brain—nicotine dependence	0.000468	0.0136	CbGeAlD
Ergotamine—ABCB1—brain—nicotine dependence	0.000307	0.00892	CbGeAlD
Ergotamine—HTR1D—GPCR ligand binding—OPRM1—nicotine dependence	0.000237	0.00198	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000237	0.00198	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000236	0.00197	CbGpPWpGaD
Ergotamine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000234	0.00195	CbGpPWpGaD
Ergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000233	0.00194	CbGpPWpGaD
Ergotamine—HTR1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000232	0.00194	CbGpPWpGaD
Ergotamine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000231	0.00193	CbGpPWpGaD
Ergotamine—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00023	0.00191	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00023	0.00191	CbGpPWpGaD
Ergotamine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00023	0.00191	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—FGD1—nicotine dependence	0.000227	0.00189	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000226	0.00188	CbGpPWpGaD
Ergotamine—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000225	0.00188	CbGpPWpGaD
Ergotamine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000225	0.00188	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000223	0.00186	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—FGD1—nicotine dependence	0.000222	0.00185	CbGpPWpGaD
Ergotamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000221	0.00184	CbGpPWpGaD
Ergotamine—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000221	0.00184	CbGpPWpGaD
Ergotamine—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.000219	0.00182	CbGpPWpGaD
Ergotamine—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000218	0.00182	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000216	0.0018	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000214	0.00179	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.000214	0.00178	CbGpPWpGaD
Ergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000213	0.00178	CbGpPWpGaD
Ergotamine—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000211	0.00176	CbGpPWpGaD
Ergotamine—HTR1F—GPCR downstream signaling—OPRM1—nicotine dependence	0.00021	0.00175	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—FGD1—nicotine dependence	0.000209	0.00174	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.000209	0.00174	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000208	0.00174	CbGpPWpGaD
Ergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000207	0.00173	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000205	0.00171	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000205	0.00171	CbGpPWpGaD
Ergotamine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000204	0.0017	CbGpPWpGaD
Ergotamine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000204	0.0017	CbGpPWpGaD
Ergotamine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000203	0.00169	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.000203	0.00169	CbGpPWpGaD
Ergotamine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000201	0.00167	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000201	0.00167	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—OPRM1—nicotine dependence	0.000198	0.00165	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—FGD1—nicotine dependence	0.000198	0.00165	CbGpPWpGaD
Ergotamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000197	0.00164	CbGpPWpGaD
Ergotamine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000196	0.00163	CbGpPWpGaD
Ergotamine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000195	0.00163	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.000194	0.00162	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000193	0.00161	CbGpPWpGaD
Ergotamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000193	0.00161	CbGpPWpGaD
Ergotamine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000192	0.0016	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—OPRM1—nicotine dependence	0.000191	0.00159	CbGpPWpGaD
Ergotamine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00019	0.00158	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000189	0.00158	CbGpPWpGaD
Ergotamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000187	0.00156	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000187	0.00155	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000186	0.00155	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000186	0.00155	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000185	0.00154	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—AKR1B10—nicotine dependence	0.000185	0.00154	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000183	0.00153	CbGpPWpGaD
Ergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000183	0.00152	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000182	0.00152	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—OPRM1—nicotine dependence	0.00018	0.0015	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000177	0.00148	CbGpPWpGaD
Ergotamine—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000177	0.00147	CbGpPWpGaD
Ergotamine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000176	0.00147	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000175	0.00146	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AKR1B10—nicotine dependence	0.000175	0.00145	CbGpPWpGaD
Ergotamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000174	0.00145	CbGpPWpGaD
Ergotamine—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.000172	0.00143	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000171	0.00142	CbGpPWpGaD
Ergotamine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00017	0.00141	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000169	0.00141	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000169	0.00141	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000169	0.0014	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000168	0.0014	CbGpPWpGaD
Ergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000168	0.0014	CbGpPWpGaD
Ergotamine—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.000168	0.0014	CbGpPWpGaD
Ergotamine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000167	0.00139	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000167	0.00139	CbGpPWpGaD
Ergotamine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000166	0.00138	CbGpPWpGaD
Ergotamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000166	0.00138	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000164	0.00136	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000161	0.00134	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000161	0.00134	CbGpPWpGaD
Ergotamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00016	0.00133	CbGpPWpGaD
Ergotamine—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000158	0.00131	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000158	0.00131	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000157	0.00131	CbGpPWpGaD
Ergotamine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000155	0.00129	CbGpPWpGaD
Ergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000154	0.00128	CbGpPWpGaD
Ergotamine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000153	0.00127	CbGpPWpGaD
Ergotamine—HTR1F—GPCR downstream signaling—DRD2—nicotine dependence	0.000152	0.00126	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.00015	0.00125	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000149	0.00124	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.000147	0.00122	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000146	0.00122	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000146	0.00122	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000146	0.00122	CbGpPWpGaD
Ergotamine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000145	0.00121	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000143	0.00119	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—DRD2—nicotine dependence	0.000143	0.00119	CbGpPWpGaD
Ergotamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000142	0.00118	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000139	0.00116	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—DRD2—nicotine dependence	0.000138	0.00115	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000134	0.00112	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—FGD1—nicotine dependence	0.000134	0.00112	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000133	0.00111	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.000133	0.0011	CbGpPWpGaD
Ergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000132	0.0011	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000132	0.0011	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000131	0.00109	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—FGD1—nicotine dependence	0.000131	0.00109	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—WASF2—nicotine dependence	0.00013	0.00109	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—DRD2—nicotine dependence	0.00013	0.00108	CbGpPWpGaD
Ergotamine—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.000128	0.00107	CbGpPWpGaD
Ergotamine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.000127	0.00106	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000127	0.00106	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000127	0.00106	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—WASF1—nicotine dependence	0.000125	0.00104	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000123	0.00103	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—FGD1—nicotine dependence	0.000123	0.00103	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—WASF2—nicotine dependence	0.000123	0.00102	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.000122	0.00102	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000122	0.00101	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000121	0.00101	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000119	0.000994	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000118	0.000986	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—WASF1—nicotine dependence	0.000118	0.000982	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000116	0.000965	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000115	0.000956	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.000115	0.000955	CbGpPWpGaD
Ergotamine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000114	0.000948	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—OPRM1—nicotine dependence	0.000113	0.000937	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000112	0.000933	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000112	0.000931	CbGpPWpGaD
Ergotamine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000111	0.000921	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.00011	0.000916	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000109	0.000907	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000108	0.000902	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000108	0.000897	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—OPRM1—nicotine dependence	0.000106	0.000884	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000104	0.000868	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000104	0.000863	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	0.000104	0.000862	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000101	0.000844	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000101	0.000838	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.0001	0.000834	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.0001	0.000833	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	9.99e-05	0.000832	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	9.96e-05	0.000829	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	9.94e-05	0.000828	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	9.7e-05	0.000808	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	9.53e-05	0.000794	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	9.52e-05	0.000793	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	9.5e-05	0.000791	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	9.41e-05	0.000784	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	9.14e-05	0.000762	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	9.09e-05	0.000757	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	9.04e-05	0.000753	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	8.92e-05	0.000743	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	8.83e-05	0.000735	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	8.81e-05	0.000734	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	8.79e-05	0.000732	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	8.78e-05	0.000731	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—FGD1—nicotine dependence	8.77e-05	0.000731	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	8.65e-05	0.000721	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	8.65e-05	0.00072	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	8.63e-05	0.000719	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	8.62e-05	0.000718	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	8.46e-05	0.000705	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	8.45e-05	0.000704	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	8.41e-05	0.0007	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—WASF2—nicotine dependence	8.34e-05	0.000694	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	8.3e-05	0.000691	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—WASF2—nicotine dependence	8.16e-05	0.00068	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—DRD2—nicotine dependence	8.14e-05	0.000678	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	8.1e-05	0.000675	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—WASF1—nicotine dependence	7.99e-05	0.000666	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	7.98e-05	0.000665	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	7.87e-05	0.000655	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	7.85e-05	0.000654	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	7.85e-05	0.000654	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—WASF1—nicotine dependence	7.83e-05	0.000652	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	7.75e-05	0.000645	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	7.71e-05	0.000642	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	7.69e-05	0.00064	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—DRD2—nicotine dependence	7.68e-05	0.000639	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—WASF2—nicotine dependence	7.67e-05	0.000639	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	7.63e-05	0.000635	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	7.54e-05	0.000628	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	7.49e-05	0.000624	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	7.47e-05	0.000622	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—WASF1—nicotine dependence	7.35e-05	0.000612	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	7.23e-05	0.000603	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	7.2e-05	0.000599	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	7.2e-05	0.000599	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	7.14e-05	0.000595	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	7.14e-05	0.000594	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	7.05e-05	0.000587	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	6.94e-05	0.000578	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	6.89e-05	0.000574	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	6.84e-05	0.00057	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	6.81e-05	0.000567	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	6.62e-05	0.000551	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	6.57e-05	0.000547	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	6.54e-05	0.000544	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	6.44e-05	0.000537	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	6.26e-05	0.000521	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	6.25e-05	0.000521	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	6.22e-05	0.000518	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	6.19e-05	0.000515	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	6.18e-05	0.000514	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	6.16e-05	0.000513	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	6.12e-05	0.00051	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	5.96e-05	0.000497	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	5.93e-05	0.000494	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	5.92e-05	0.000493	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	5.69e-05	0.000474	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	5.68e-05	0.000473	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	5.68e-05	0.000473	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	5.56e-05	0.000463	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	5.56e-05	0.000463	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—WASF2—nicotine dependence	5.46e-05	0.000455	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	5.37e-05	0.000447	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	5.37e-05	0.000447	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	5.34e-05	0.000445	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CYP2A7—nicotine dependence	5.33e-05	0.000444	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	5.26e-05	0.000438	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—WASF1—nicotine dependence	5.23e-05	0.000436	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—DRD2—nicotine dependence	5.2e-05	0.000433	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	5.16e-05	0.00043	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	5.15e-05	0.000429	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	5.11e-05	0.000426	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—DRD2—nicotine dependence	5.09e-05	0.000424	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	5.04e-05	0.00042	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	4.89e-05	0.000407	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—DRD2—nicotine dependence	4.79e-05	0.000399	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.71e-05	0.000393	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	4.69e-05	0.00039	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	4.64e-05	0.000386	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	4.54e-05	0.000378	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	4.45e-05	0.000371	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	4.26e-05	0.000355	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	4.22e-05	0.000351	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	4.02e-05	0.000335	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	3.88e-05	0.000323	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	3.86e-05	0.000322	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	3.7e-05	0.000308	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	3.35e-05	0.000279	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	3.29e-05	0.000274	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	3.28e-05	0.000273	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	3.05e-05	0.000254	CbGpPWpGaD
